healthcarema

Debt has been a key financing source for healthcare M&A transactions. The availability of debt capital markets with the attractive rate environment has been a key reason for the heightened deal volume we have experienced within healthcare.  Macroeconomic changes in the last few months have impacted deal activity across the economy, including specific areas within healthcare services. In this episode, Provident’s Scott Davis and AJ Shekar are joined by Pete Coffin of Twin Brook Capital Partners to discuss what is happening in the debt capital markets today.

Provident Healthcare Partners’ Scott Davis, Eric Major,  and Kevin McDermott discuss the key drivers for activity within healthcare services M&A this past year, the more active sectors in the space, challenges faced in 2021, what we can expect to see in 2022, and the key takeaways from the annual JP Morgan Healthcare conference.

New episodes are released on a quarterly basis, make sure you subscribe so you do not miss future episodes.

Provident Healthcare Partners’ AJ Shekar and Eric Major are joined by Hal Katz, Partner at Husch Blackwell to discuss how to best prepare for all phases of a transaction, focusing on planning ahead for an optimal deal structure, regulatory considerations, and expectations for legal due diligence.

Provident Healthcare Partners’ AJ Shekar and Kevin McDermott are joined by Kyle Lattner, Principal of Waud Capital Partners, to discuss how the pandemic has impacted healthcare deal volume and investment since COVID-19 started in March 2020, as well as private equity’s outlook for the remainder of 2021.

Provident Healthcare Partners’ Kevin Palamara, AJ Shekar, and Jake Vesely  are joined by Les Levinson of Robinson and Cole to discuss the recent investment activity we’ve seen in the home health and hospice space, key transaction and legal considerations for groups considering a process, predictions for M&A activity and valuations going into 2021, and more.  

Tax Implications of a transaction are an important consideration for shareholders as they begin their planning and preparation process around a potential deal. In this episode, Provident Healthcare Partners’ AJ Shekar and Dustin Thompson are joined by Yaury Jattin, Principal at Kaufman Rossin, a full service CPA firm, to provide an overview of the key components of tax implications.

From an M&A perspective, healthcare is an interesting frontier that you may want to look into as an investor. On the other hand, as the industry works itself through the COVID-19 pandemic, it is a good time for owners who want an exit to start contemplating a sell. Whether you’re an owner looking to sell or an investor looking to dip their toes into healthcare, you’d be surprised to know that there is so much to learn about regulation and valuation in M&A transactions in this particular industry. Before entering a transaction, you may want to consider talking to your regulatory attorney. Dive right into this conversation between Domenic Rinaldi and healthcare regulatory attorney, Joshua Freemire of Epstein Becker & Green to learn more.

Love the show? Subscribe, rate, review, and share!

• Here’s How »

Join the M&A Unplugged Community today:

• k2adviser.com
• M&A Unplugged Twitter
• M&A Unplugged Facebook
• M&A Unplugged Instagram

Since the lock downs took effect across the country in March, markets have tightened up and most processes were either put on hold or delayed. Provident Healthcare Partners’ Steven Grassa and Abe M’Bodj discuss the impact this pandemic has had on M&A activity and what we can expect to see moving forward.

Quality of Earnings is a process that is integrally involved in every one of the transactions run by Provident. In this episode, Provident Healthcare Partners’ Scott Davis and Dustin Thompson are joined by Aaron Cohen of Citrin Cooperman, an accounting firm that provides transaction advisory services, to provide an overview of the key components of a Quality of Earnings.